These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9096658)

  • 1. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
    Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
    Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
    Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
    Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
    Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
    Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute leukemia in association with Langerhans cell histiocytosis.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
    Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
    López-Andreu JA; Ferris J; Verdeguer A; Esquembre C; Castel V
    Cancer; 1994 Sep; 74(5):1650-2. PubMed ID: 7864932
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone.
    Haupt R; Comelli A; Rosanda C; Sessarego M; De Bernardi B
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):255-7. PubMed ID: 8498650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
    Sugita K; Furukawa T; Tsuchida M; Okawa Y; Nakazawa S; Akatsuka J; Ohira M; Nishimura K
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):99-104. PubMed ID: 8447565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
    Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
    Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.
    Kager L; Heise A; Minkov M; Möbius D; Kotte W; Schulte-Overberg U; Henze G; Gadner H
    Pediatr Hematol Oncol; 1999; 16(3):251-6. PubMed ID: 10326224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
    Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
    Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP-16 and the treatment of histiocytosis.
    Gadner H; Ladisch S; Aricó M; Broadbent V; Jakobson A; Komp D; Nicholson S
    Eur J Pediatr; 1994 May; 153(5):389. PubMed ID: 8033933
    [No Abstract]   [Full Text] [Related]  

  • 13. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-related acute promyelocytic leukemia.
    Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
    Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
    Egeler RM
    Cancer; 1995 Jan; 75(1):134-6. PubMed ID: 7804969
    [No Abstract]   [Full Text] [Related]  

  • 16. Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study.
    Ceci A; de Terlizzi M; Colella R; Balducci D; Toma MG; Zurlo MG; Macchia P; Mancini A; Indolfi P; Locurto M
    Cancer; 1988 Dec; 62(12):2528-31. PubMed ID: 3056605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis and etoposide: risks vs. benefits.
    D'Angio GJ
    Med Pediatr Oncol; 1994; 23(2):69-71. PubMed ID: 8202044
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
    Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
    Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
    Nichols CR; Breeden ES; Loehrer PJ; Williams SD; Einhorn LH
    J Natl Cancer Inst; 1993 Jan; 85(1):36-40. PubMed ID: 7677934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.